+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biologics Testing Service Market - Global Forecast 2026-2032- Product Image
Biologics Testing Service Market - Global Forecast 2026-2032- Product Image
Sale

Biologics Testing Service Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6150500
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biologics Testing Service Market is projected to reach USD 700.47 Million in 2026. It is expected to continue growing at a CAGR of 8.46%, reaching USD 1.13 Billion by 2032.

Biologics Testing Services: Executive Overview

Biologics testing services support the development, manufacturing, release, and lifecycle management of products such as vaccines, recombinant proteins, monoclonal antibodies, cell therapies, and gene therapies. The field spans identity, purity, potency, sterility, mycoplasma, endotoxin, adventitious-agent, stability, comparability, and process-related testing. Its importance is increasing as biologics become more structurally complex and as regulators place greater emphasis on product consistency, contamination control, validated analytical methods, and evidence generated throughout the product lifecycle.

How Complexity and Regulation Are Reshaping Testing

The testing landscape is shifting from discrete release assays toward integrated, risk-based control strategies covering raw materials, processes, facilities, and finished products. Advanced modalities require broader characterization, orthogonal methods, and stronger comparability packages when manufacturing processes change. Continuous manufacturing, decentralized production, biosimilars, cell and gene therapies, and increasingly sophisticated supply chains are also encouraging greater use of automated workflows, reference standards, data integrity controls, and validated platforms that can transfer reliably across laboratories and jurisdictions.

Artificial Intelligence Strengthens Interpretation and Operations

Artificial intelligence can improve biologics testing by supporting image analysis, chromatographic and spectrometric interpretation, anomaly detection, assay development, sample prioritization, and laboratory scheduling. Its most defensible near-term applications are decision support and workflow optimization, where outputs remain reviewable by qualified scientists. Adoption requires representative training data, documented model performance, change control, cybersecurity, audit trails, and clear human accountability. AI should complement-not replace-validated methods, scientific judgment, and regulatory expectations for traceable evidence.

Regional Insights Across the Global Testing Network

North America combines mature biopharmaceutical development with strong regulatory expectations and advanced laboratory infrastructure. Europe emphasizes harmonized quality systems, comparability, and cross-border manufacturing controls, while Asia-Pacific is expanding its role in biologics production, clinical development, and analytical capacity. Latin America is strengthening local manufacturing and regulatory capabilities, with testing access and technology transfer remaining important considerations. The Middle East is investing in life-science infrastructure and supply resilience, whereas Africa presents opportunities linked to vaccine, diagnostics, and biomanufacturing capacity, alongside uneven laboratory resources and accreditation coverage.

Group Insights: Trade, Regulation, and Manufacturing Alignment

ASEAN markets are relevant to regional supply-chain diversification and the gradual development of biologics manufacturing and quality infrastructure. BRICS members span major production, research, and healthcare systems, but regulatory maturity and laboratory capabilities differ substantially. The European Union benefits from regulatory coordination and shared quality principles. G7 members generally contribute advanced research, manufacturing, and analytical capabilities, while NATO countries increasingly consider health-security resilience and trusted supply chains. GCC markets are building healthcare and pharmaceutical capacity, making accreditation, workforce development, and standardized testing frameworks particularly important.

Country Insights for Priority Biologics Markets

The United States and Canada offer highly developed testing ecosystems supported by sophisticated sponsors, regulators, and contract laboratories. Germany, France, Italy, Spain, and the United Kingdom provide strong European research, manufacturing, and quality infrastructures, with alignment and method transfer remaining central to cross-border operations. China, Japan, South Korea, India, and Australia combine significant scientific and manufacturing capabilities with distinct regulatory pathways and growing demand for locally accessible testing. Brazil, Mexico, and Russia have important pharmaceutical and healthcare bases, while infrastructure consistency, international method comparability, and access to specialized assays remain key considerations across their markets.

Actions for Leaders Building Resilient Testing Strategies

Industry leaders should map testing requirements across the entire product lifecycle and connect each assay to a defined quality risk. They should prioritize validated, orthogonal methods for complex modalities; establish early comparability plans; and qualify laboratories, reference materials, instruments, and data systems before pivotal milestones. Investments in automation and AI should be governed through model validation, auditability, cybersecurity, and human review. Organizations should also use dual-source strategies where appropriate, maintain qualified regional capabilities, monitor regulatory changes, and develop specialist training in advanced analytics, contamination control, and data integrity.

Methodology for the Executive Assessment

This executive assessment uses the supplied market definition-biologics testing services-as its analytical scope. It synthesizes established principles from biologics quality control, pharmaceutical manufacturing, laboratory accreditation, regulatory science, and global life-science infrastructure. The analysis organizes findings by technology and workflow shifts, AI applications, required regions, economic and policy groups, and specified countries. Claims are presented qualitatively and avoid market estimates, shares, forecasts, company references, and unsupported numerical assertions. Regional comparisons reflect differences in regulatory maturity, manufacturing activity, laboratory capacity, and healthcare-system development.

Conclusion: Quality Infrastructure Is a Strategic Differentiator

Biologics testing services are becoming a strategic component of product development and supply-chain resilience rather than a standalone compliance function. Success depends on integrating scientifically appropriate assays, robust quality systems, interoperable data, qualified personnel, and regionally resilient laboratory capacity. As biologics diversify and manufacturing networks become more distributed, organizations that combine rigorous validation with responsible automation and AI governance will be better positioned to demonstrate consistency, manage change, and sustain regulatory confidence.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biologics Testing Service Market, by Service Type
7.1. Introduction
7.2. Bioassay
7.2.1. Binding Assay
7.2.1.1. Competitive
7.2.1.2. Indirect
7.2.1.3. Sandwich
7.2.2. Cell Based Assay
7.2.3. Potency Assay
7.3. Microbiological
7.3.1. Bioburden Testing
7.3.2. Endotoxin Testing
7.3.3. Sterility Testing
7.4. Physicochemical
7.4.1. Chromatography
7.4.1.1. Gas Chromatography
7.4.1.2. High Performance Liquid Chromatography
7.4.1.3. Ultra High Performance Liquid Chromatography
7.4.2. Spectroscopy
7.4.2.1. Fourier Transform Infrared
7.4.2.2. Nuclear Magnetic Resonance
7.4.2.3. Ultraviolet Visible
7.4.3. Thermal Analysis
7.4.3.1. Differential Scanning Calorimetry
7.4.3.2. Dynamic Mechanical Analysis
7.4.3.3. Thermogravimetric Analysis
8. Biologics Testing Service Market, by Technology
8.1. Introduction
8.2. Chromatography
8.2.1. Gas Chromatography
8.2.2. High Performance Liquid Chromatography
8.2.3. Ultra High Performance Liquid Chromatography
8.3. ELISA
8.3.1. Competitive
8.3.2. Indirect
8.3.3. Sandwich
8.4. Mass Spectrometry
8.4.1. GC MS
8.4.2. LC MS
8.5. PCR
8.5.1. qPCR
8.5.2. RT PCR
8.6. Spectroscopy
8.6.1. Fourier Transform Infrared
8.6.2. Nuclear Magnetic Resonance
8.6.3. Ultraviolet Visible
9. Biologics Testing Service Market, by Application
9.1. Introduction
9.2. Academic Research
9.2.1. Basic Research
9.2.2. Translational Research
9.3. Biotechnology
9.3.1. Cell Therapy
9.3.2. Gene Therapy
9.4. Food Safety
9.4.1. Contaminant Detection
9.4.2. Nutritional Analysis
9.5. Pharmaceuticals
9.5.1. Drug Discovery
9.5.2. Process Development
9.5.3. Quality Control
10. Biologics Testing Service Market, by End User
10.1. Introduction
10.2. Academic Institutes
10.2.1. Research Institutes
10.2.2. Universities
10.3. Biotechnology Companies
10.3.1. Large Biotechnology Companies
10.3.2. Small Biotechnology Companies
10.4. Contract Research Organizations
10.4.1. Large CROs
10.4.2. Small CROs
10.5. Pharmaceutical Companies
10.5.1. Generics
10.5.2. Innovators
11. Biologics Testing Service Market, by Sample Type
11.1. Introduction
11.2. Cell Cultures
11.2.1. Mammalian Cell Cultures
11.2.2. Microbial Cell Cultures
11.3. Monoclonal Antibodies
11.3.1. Chimeric
11.3.2. Humanized
11.3.3. Murine
11.4. Peptides
11.4.1. Natural Peptides
11.4.2. Synthetic Peptides
11.5. Proteins
11.5.1. Structural Proteins
11.5.2. Therapeutic Proteins
11.6. Vaccines
11.6.1. Bacterial Vaccines
11.6.2. Recombinant Vaccines
11.6.3. Viral Vaccines
12. Biologics Testing Service Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Biologics Testing Service Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Biologics Testing Service Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Agilent Technologies Inc
16.3. Bio-Rad Laboratories Inc
16.4. bioMérieux SA
16.5. Charles River Laboratories International Inc
16.6. Danaher Corporation
16.7. Eurofins Scientific SE
16.8. F. Hoffmann-La Roche Ltd
16.9. FUJIFILM Corporation
16.10. GenScript Biotech Corp
16.11. Gilead Sciences Inc
16.12. ICON plc
16.13. Intertek Group plc
16.14. IQVIA Holdings Inc
16.15. Laboratory Corporation of America Holdings
16.16. Lonza Group Ltd
16.17. Merck KGaA
16.18. Pace Analytical Services Inc
16.19. Samsung Biologics
16.20. Sartorius AG
16.21. SGS SA
16.22. Syngene International Limited
16.23. Thermo Fisher Scientific Inc
16.24. Toxikon Corporation
16.25. WuXi AppTec Co Ltd
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Biologics Testing Service Market, Years Considered for the Study
FIGURE 2. Global Biologics Testing Service Market, Research Design
FIGURE 3. Global Biologics Testing Service Market, Research Framework
FIGURE 4. Global Biologics Testing Service Market, Data Triangulation
FIGURE 5. Global Biologics Testing Service Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Biologics Testing Service Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 7. Global Biologics Testing Service Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Biologics Testing Service Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Biologics Testing Service Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Biologics Testing Service Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Biologics Testing Service Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Biologics Testing Service Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Biologics Testing Service Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Biologics Testing Service Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 15. Global Biologics Testing Service Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Biologics Testing Service Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Biologics Testing Service Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Biologics Testing Service Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Biologics Testing Service Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Biologics Testing Service Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Biologics Testing Service Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Biologics Testing Service Market Segmentation & Coverage
TABLE 2. Global Biologics Testing Service Market Size, 2017-2032 (USD Million)
TABLE 3. Global Biologics Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 4. Global Bioassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Bioassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Bioassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Binding Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Binding Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Binding Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Competitive Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Competitive Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Competitive Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Indirect Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Indirect Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Indirect Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Sandwich Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Sandwich Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Sandwich Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Cell Based Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Cell Based Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Cell Based Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Potency Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Potency Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Potency Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Microbiological Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Microbiological Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Microbiological Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Bioburden Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Bioburden Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Bioburden Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Endotoxin Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Endotoxin Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Endotoxin Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Sterility Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Sterility Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Sterility Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Physicochemical Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Physicochemical Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Physicochemical Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Gas Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Gas Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Gas Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global High Performance Liquid Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global High Performance Liquid Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global High Performance Liquid Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Ultra High Performance Liquid Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Ultra High Performance Liquid Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Ultra High Performance Liquid Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Spectroscopy Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Spectroscopy Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Spectroscopy Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Fourier Transform Infrared Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Fourier Transform Infrared Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Fourier Transform Infrared Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Nuclear Magnetic Resonance Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Nuclear Magnetic Resonance Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Nuclear Magnetic Resonance Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Ultraviolet Visible Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Ultraviolet Visible Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Ultraviolet Visible Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Thermal Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Thermal Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Thermal Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Differential Scanning Calorimetry Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Differential Scanning Calorimetry Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Differential Scanning Calorimetry Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Dynamic Mechanical Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Dynamic Mechanical Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Dynamic Mechanical Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Thermogravimetric Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Thermogravimetric Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Thermogravimetric Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Biologics Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 77. Global Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Gas Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Gas Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Gas Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global High Performance Liquid Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global High Performance Liquid Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global High Performance Liquid Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Ultra High Performance Liquid Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Ultra High Performance Liquid Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Ultra High Performance Liquid Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global ELISA Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global ELISA Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global ELISA Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Competitive Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Competitive Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Competitive Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Indirect Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Indirect Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Indirect Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Sandwich Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Sandwich Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Sandwich Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global GC MS Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global GC MS Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global GC MS Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global LC MS Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global LC MS Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global LC MS Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global qPCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global qPCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global qPCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global RT PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global RT PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global RT PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Spectroscopy Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Spectroscopy Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Spectroscopy Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Fourier Transform Infrared Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Fourier Transform Infrared Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Fourier Transform Infrared Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Nuclear Magnetic Resonance Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Nuclear Magnetic Resonance Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Nuclear Magnetic Resonance Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Ultraviolet Visible Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Ultraviolet Visible Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Ultraviolet Visible Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Biologics Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. Global Academic Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Academic Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Academic Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Basic Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Basic Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Basic Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Translational Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Translational Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Translational Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Global Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. Global Cell Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. Global Gene Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Global Gene Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. Global Gene Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 150. Global Food Safety Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Global Food Safety Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. Global Food Safety Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. Global Contaminant Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Global Contaminant Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. Global Contaminant Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 156. Global Nutritional Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Global Nutritional Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. Global Nutritional Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. Global Pharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Global Pharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. Global Pharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 162. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 165. Global Process Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Global Process Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. Global Process Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 168. Global Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Global Quality Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. Global Quality Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. Global Biologics Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Global Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Global Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. Global Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 175. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 178. Global Universities Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Global Universities Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. Global Universities Market Size, by Country, 2017-2032 (USD Million)
TABLE 181. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 184. Global Large Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 185. Global Large Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. Global Large Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 187. Global Small Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 188. Global Small Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. Global Small Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 190. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 193. Global Large CROs Market Size, by Region, 2017-2032 (USD Million)
TABLE 194. Global Large CROs Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. Global Large CROs Market Size, by Country, 2017-2032 (USD Million)
TABLE 196. Global Small CROs Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Global Small CROs Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. Global Small CROs Market Size, by Country, 2017-2032 (USD Million)
TABLE 199. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 200. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 202. Global Generics Market Size, by Region, 2017-2032 (USD Million)
TABLE 203. Global Generics Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. Global Generics Market Size, by Country, 2017-2032 (USD Million)
TABLE 205. Global Innovators Market Size, by Region, 2017-2032 (USD Million)
TABLE 206. Global Innovators Market Size, by Group, 2017-2032 (USD Million)
TABLE 207. Global Innovators Market Size, by Country, 2017-2032 (USD Million)
TABLE 208. Global Biologics Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 209. Global Cell Cultures Market Size, by Region, 2017-2032 (USD Million)
TABLE 210. Global Cell Cultures Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. Global Cell Cultures Market Size, by Country, 2017-2032 (USD Million)
TABLE 212. Global Mammalian Cell Cultures Market Size, by Region, 2017-2032 (USD Million)
TABLE 213. Global Mammalian Cell Cultures Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. Global Mammalian Cell Cultures Market Size, by Country, 2017-2032 (USD Million)
TABLE 215. Global Microbial Cell Cultures Market Size, by Region, 2017-2032 (USD Million)
TABLE 216. Global Microbial Cell Cultures Market Size, by Group, 2017-2032 (USD Million)
TABLE 217. Global Microbial Cell Cultures Market Size, by Country, 2017-2032 (USD Million)
TABLE 218. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 219. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 220. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 221. Global Chimeric Market Size, by Region, 2017-2032 (USD Million)
TABLE 222. Global Chimeric Market Size, by Group, 2017-2032 (USD Million)
TABLE 223. Global Chimeric Market Size, by Country, 2017-2032 (USD Million)
TABLE 224. Global Humanized Market Size, by Region, 2017-2032 (USD Million)
TABLE 225. Global Humanized Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. Global Humanized Market Size, by Country, 2017-2032 (USD Million)
TABLE 227. Global Murine Market Size, by Region, 2017-2032 (USD Million)
TABLE 228. Global Murine Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. Global Murine Market Size, by Country, 2017-2032 (USD Million)
TABLE 230. Global Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 231. Global Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 232. Global Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 233. Global Natural Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 234. Global Natural Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. Global Natural Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 236. Global Synthetic Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 237. Global Synthetic Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 238. Global Synthetic Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 239. Global Proteins Market Size, by Region, 2017-2032 (USD Million)
TABLE 240. Global Proteins Market Size, by Group, 2017-2032 (USD Million)
TABLE 241. Global Proteins Market Size, by Country, 2017-2032 (USD Million)
TABLE 242. Global Structural Proteins Market Size, by Region, 2017-2032 (USD Million)
TABLE 243. Global Structural Proteins Market Size, by Group, 2017-2032 (USD Million)
TABLE 244. Global Structural Proteins Market Size, by Country, 2017-2032 (USD Million)
TABLE 245. Global Therapeutic Proteins Market Size, by Region, 2017-2032 (USD Million)
TABLE 246. Global Therapeutic Proteins Market Size, by Group, 2017-2032 (USD Million)
TABLE 247. Global Therapeutic Proteins Market Size, by Country, 2017-2032 (USD Million)
TABLE 248. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 249. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 250. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 251. Global Bacterial Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 252. Global Bacterial Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 253. Global Bacterial Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 254. Global Recombinant Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 255. Global Recombinant Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 256. Global Recombinant Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 257. Global Viral Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 258. Global Viral Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 259. Global Viral Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 260. Global Biologics Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 261. Asia-Pacific Biologics Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 262. Asia-Pacific Biologics Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 263. Asia-Pacific Biologics Testing Service Market Size, by Bioassay, 2017-2032 (USD Million)
TABLE 264. Asia-Pacific Biologics Testing Service Market Size, by Binding Assay, 2017-2032 (USD Million)
TABLE 265. Asia-Pacific Biologics Testing Service Market Size, by Microbiological, 2017-2032 (USD Million)
TABLE 266. Asia-Pacific Biologics Testing Service Market Size, by Physicochemical, 2017-2032 (USD Million)
TABLE 267. Asia-Pacific Biologics Testing Service Market Size, by Chromatography, 2017-2032 (USD Million)
TABLE 268. Asia-Pacific Biologics Testing Service Market Size, by Spectroscopy, 2017-2032 (USD Million)
TABLE 269. Asia-Pacific Biologics Testing Service Market Size, by Thermal Analysis, 2017-2032 (USD Million)
TABLE 270. Asia-Pacific Biologics Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 271. Asia-Pacific Biologics Testing Service Market Size, by Chromatography, 2017-2032 (USD Million)
TABLE 272. Asia-Pacific Biologics Testing Service Market Size, by ELISA, 2017-2032 (USD Million)
TABLE 273. Asia-Pacific Biologics Testing Service Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 274. Asia-Pacific Biologics Testing Service Market Size, by PCR, 2017-2032 (USD Million)
TABLE 275. Asia-Pacific Biologics Testing Service Market Size, by Spectroscopy, 2017-2032 (USD Million)
TABLE 276. Asia-Pacific Biologics Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 277. Asia-Pacific Biologics Testing Service Market Size, by Academic Research, 2017-2032 (USD Million)
TABLE 278. Asia-Pacific Biologics Testing Service Market Size, by Biotechnology, 2017-2032 (USD Million)
TABLE 279. Asia-Pacific Biologics Testing Service Market Size, by Food Safety, 2017-2032 (USD Million)
TABLE 280. Asia-Pacific Biologics Testing Service Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 281. Asia-Pacific Biologics Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 282. Asia-Pacific Biologics Testing Service Market Size, by Academic Institutes, 2017-2032 (USD Million)
TABLE 283. Asia-Pacific Biologics Testing Service Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 284. Asia-Pacific Biologics Testing Service Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 285. Asia-Pacific Biologics Testing Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 286. Asia-Pacific Biologics Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 287. Asia-Pacific Biologics Testing Service Market Size, by Cell Cultures, 2017-2032 (USD Million)
TABLE 288. Asia-Pacific Biologics Testing Service Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 289. Asia-Pacific Biologics Testing Service Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 290. Asia-Pacific Biologics Testing Service Market Size, by Proteins, 2017-2032 (USD Million)
TABLE 291. Asia-Pacific Biologics Testing Service Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 292. North America Biologics Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 293. North America Biologics Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 294. North America Biologics Testing Service Market Size, by Bioassay, 2017-2032 (USD Million)
TABLE 295. North America Biologics Testing Service Market Size, by Binding Assay, 2017-2032 (USD Million)
TABLE 296. North America Biologics Testing Service Market Size, by Microbiological, 2017-2032 (USD Million)
TABLE 297. North America Biologics Testing Service Market Size, by Physicochemical, 2017-2032 (USD Million)
TABLE 298. North America Biologics Testing Service Market Size, by Chromatography, 2017-2032 (USD Million)
TABLE 299. North America Biologics Testing Service Market Size, by Spectroscopy, 2017-2032 (USD Million)
TABLE 300. North America Biologics Testing Service Market Size, by Thermal Analysis, 2017-2032 (USD Million)
TABLE 301. North America Biologics Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 302. North America Biologics Testing Service Market Size, by Chromatography, 2017-2032 (USD Million)
TABLE 303. North America Biologics Testing Service Market Size, by ELISA, 2017-2032 (USD Million)
TABLE 304. North America Biologics Testing Service Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 305. North America Biologics Testing Service Market Size, by PCR, 2017-2032 (USD Million)
TABLE 306. North America Biologics Testing Service Market Size, by Spectroscopy, 2017-2032 (USD Million)
TABLE 307. North America Biologics Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 308. North America Biologics Testing Service Market Size, by Academic Research, 2017-2032 (USD Million)
TABLE 309. North America Biologics Testing Service Market Size, by Biotechnology, 2017-2032 (USD Million)
TABLE 310. North America Biologics Testing Service Market Size, by Food Safety, 2017-2032 (USD Million)
TABLE 311. North America Biologics Testing Service Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 312. North America Biologics Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. North America Biologics Testing Service Market Size, by Academic Institutes, 2017-2032 (USD Million)
TABLE 314. North America Biologics Testing Service Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 315. North America Biologics Testing Service Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 316. North America Biologics Testing Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 317. North America Biologics Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 318. North America Biologics Testing Service Market Size, by Cell Cultures, 2017-2032 (USD Million)
TABLE 319. North America Biologics Testing Service Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 320. North America Biologics Testing Service Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 321. North America Biologics Testing Service Market Size, by Proteins, 2017-2032 (USD Million)
TABLE 322. North America Biologics Testing Service Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 323. Latin America Biologics Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 324. Latin America Biologics Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 325. Latin America Biologics Testing Service Market Size, by Bioassay, 2017-2032 (USD Million)
TABLE 326. Latin America Biologics Testing Service Market Size, by Binding Assay, 2017-2032 (USD Million)
TABLE 327. Latin America Biologics Testing Service Market Size, by Microbiological, 2017-2032 (USD Million)
TABLE 328. Latin America Biologics Testing Service Market Size, by Physicochemical, 2017-2032 (USD Million)
TABLE 329. Latin America Biologics Testing Service Market Size, by Chromatography, 2017-2032 (USD Million)
TABLE 330. Latin America Biologics Testing Service Market Size, by Spectroscopy, 2017-2032 (USD Million)
TABLE 331. Latin America Biologics Testing Service Market Size, by Thermal Analysis, 2017-2032 (USD Million)
TABLE 332. Latin America Biologics Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 333. Latin America Biologics Testing Service Market Size, by Chromatography, 2017-2032 (USD Million)
TABLE 334. Latin America Biologics Testing Service Market Size, by ELISA, 2017-2032 (USD Million)
TABLE 335. Latin America Biologics Testing Service Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 336. Latin America Biologics Testing Service Market Size, by PCR, 2017-2032 (USD Million)
TABLE 337. Latin America Biologics Testing Service Market Size, by Spectroscopy, 2017-2032 (USD Million)
TABLE 338. Latin America Biologics Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 339. Latin America Biologics Testing Service Market Size, by Academic Research, 2017-2032 (USD Million)
TABLE 340. Latin America Biologics Testing Service Market Size, by Biotechnology, 2017-2032 (USD Million)
TABLE 341. Latin America Biologics Testing Service Market Size, by Food Safety, 2017-2032 (USD Million)
TABLE 342. Latin America Biologics Testing Service Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 343. Latin America Biologics Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 344. Latin America Biologics Testing Service Market Size, by Academic Institutes, 2017-2032 (USD Million)
TABLE 345. Latin America Biologics Testing Service Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 346. Latin America Biologics Testing Service Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 347. Latin America Biologics Testing Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 348. Latin America Biologics Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 349. Latin America Biologics Testing Service Market Size, by Cell Cultures, 2017-2032 (USD Million)
TABLE 350. Latin America Biologics Testing Service Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 351. Latin America Biologics Testing Service Market Size, by Peptides, 2017-2032 (USD Million)
TABLE 352. Latin America Biologics Testing Service Market Size, by Proteins, 2017-2032 (USD Million)
TABLE 353. Latin America Biologics Testing Service Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 354. Europe Biologics Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 355. Europe Biologics Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 356. Europe Biologics Testing Service Market Size, by Bioassay, 2017-2032 (USD Million)
TABLE 357. Europe Biologics Testing Service Market Size, by Binding Assay, 2017-2032 (USD Million)
TABLE 358. Europe Biologics Testing Service Market Size, by Microbiological, 2017-2032 (USD Million)
TABLE 359. Europe Biologics Testing Service Market Size, by Physicochemical, 2017-2032 (USD Million)
TABLE 360. Europe Biologics Testing Service Market Size, by Chromatography, 2017-2032 (USD Million)
TABLE 361. Europe Biologics Testing Service Market Size, by Spectroscopy, 2017-2032 (USD Million)
TABLE 362. Europe Biologics Testing Service Market Size, by Thermal Analysis, 2017-2032 (USD Million)
TABLE 363. Europe Biologics Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 364. Europe Biologics Testing Service Market Size, by Chromatography, 2017-2032 (USD Million)
TABLE 365. Europe Biologics Testing Service Market Size, by ELISA, 2017-2032 (USD Million)
TABLE 366

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies Inc
  • Bio-Rad Laboratories Inc
  • bioMérieux SA
  • Charles River Laboratories International Inc
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Corporation
  • GenScript Biotech Corp
  • Gilead Sciences Inc
  • ICON plc
  • Intertek Group plc
  • IQVIA Holdings Inc
  • Laboratory Corporation of America Holdings
  • Lonza Group Ltd
  • Merck KGaA
  • Pace Analytical Services Inc
  • Samsung Biologics
  • Sartorius AG
  • SGS SA
  • Syngene International Limited
  • Thermo Fisher Scientific Inc
  • Toxikon Corporation
  • WuXi AppTec Co Ltd

Related Topics

Related Reports

Biologics Safety Testing Market - Global Forecast 2026-2032 - Product Image

Biologics Safety Testing Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Biologics Contract Development Market - Global Forecast 2026-2032 - Product Image

Biologics Contract Development Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Biologics Contract Development - Global Strategic Business Report - Product Image

Biologics Contract Development - Global Strategic Business Report

  • Report
  • 172 Pages
  • Global
From
Bioanalytical Testing Service Market Outlook 2026-2031: Trends in Biologics, Outsourcing, and Regulatory Compliance - Product Image

Bioanalytical Testing Service Market Outlook 2026-2031: Trends in Biologics, Outsourcing, and Regulatory Compliance

  • Report
  • 126 Pages
  • Global
From
Biologics Safety Testing Market by Product, Services, Test Type, Product & Services by Application, End User, Competition, Region - Global Forecast to 2031 - Product Image

Biologics Safety Testing Market by Product, Services, Test Type, Product & Services by Application, End User, Competition, Region - Global Forecast to 2031

  • Report
  • 527 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.